Pham P - Search Results

1

Allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility study.

Durand CM, Capoferri AA, Redd AD, Zahurak M, Rosenbloom DIS, Cash A, Avery RK, Bolaños-Meade J, Bollard CM, Bullen CK, Flexner C, Fuchs EJ, Gallant J, Gladstone DE, Gocke CD, Jones RJ, Kasamon YL, Lai J, Levis M, Luznik L, Marr KA, McHugh HL, Mehta Steinke S, Pham P, Pohlmeyer C, Pratz K, Shoham S, Wagner-Johnston N, Xu D, Siliciano JD, Quinn TC, Siliciano RF, Ambinder RF. Durand CM, et al. Among authors: pham p. Lancet HIV. 2020 Sep;7(9):e602-e610. doi: 10.1016/S2352-3018(20)30073-4. Epub 2020 Jul 7. Lancet HIV. 2020. PMID: 32649866 Free PMC article. Clinical Trial.

2

Tenofovir disoproxil fumarate for the treatment of HIV infection.

Pham PA, Gallant JE. Pham PA, et al. Expert Opin Drug Metab Toxicol. 2006 Jun;2(3):459-69. doi: 10.1517/17425255.2.3.459. Expert Opin Drug Metab Toxicol. 2006. PMID: 16863446 Review.

3

Emerging antiretroviral drug interactions.

Pham PA, Flexner C. Pham PA, et al. J Antimicrob Chemother. 2011 Feb;66(2):235-9. doi: 10.1093/jac/dkq448. Epub 2010 Dec 5. J Antimicrob Chemother. 2011. PMID: 21131695

4

Tenofovir disoproxil fumarate (Viread) for the treatment of HIV infection.

Gallant JE, Pham PA. Gallant JE, et al. Expert Rev Anti Infect Ther. 2003 Oct;1(3):415-22. doi: 10.1586/14787210.1.3.415. Expert Rev Anti Infect Ther. 2003. PMID: 15482138 Review.

5

Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1.

Zhang H, Zhou Y, Alcock C, Kiefer T, Monie D, Siliciano J, Li Q, Pham P, Cofrancesco J, Persaud D, Siliciano RF. Zhang H, et al. Among authors: pham p. J Virol. 2004 Feb;78(4):1718-29. doi: 10.1128/jvi.78.4.1718-1729.2004. J Virol. 2004. PMID: 14747537 Free PMC article.

6

Differential effects of tipranavir plus ritonavir on atorvastatin or rosuvastatin pharmacokinetics in healthy volunteers.

Pham PA, la Porte CJ, Lee LS, van Heeswijk R, Sabo JP, Elgadi MM, Piliero PJ, Barditch-Crovo P, Fuchs E, Flexner C, Cameron DW. Pham PA, et al. Antimicrob Agents Chemother. 2009 Oct;53(10):4385-92. doi: 10.1128/AAC.00449-09. Epub 2009 Aug 10. Antimicrob Agents Chemother. 2009. PMID: 19667285 Free PMC article. Clinical Trial.

7

Raltegravir-induced cerebellar ataxia.

Reiss KA, Bailey JR, Pham PA, Gallant JE. Reiss KA, et al. AIDS. 2010 Nov 13;24(17):2757. doi: 10.1097/QAD.0b013e32833fca42. AIDS. 2010. PMID: 20980871 No abstract available.

8

Beneficial pharmacokinetic interaction between atazanavir and lopinavir/ritonavir.

Pham PA, Flexner C, Parsons T, Vasist L, Fuchs E, Carson K, Agarwala S, Barditch-Crovo P. Pham PA, et al. J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):201-5. doi: 10.1097/QAI.0b013e318050d632. J Acquir Immune Defic Syndr. 2007. PMID: 17414932 Clinical Trial.

9

Unexpected drug-drug interactions in human immunodeficiency virus (HIV) therapy: induction of UGT1A1 and bile efflux transporters by Efavirenz.

Lee LS, Pham P, Flexner C. Lee LS, et al. Among authors: pham p. Ann Acad Med Singap. 2012 Dec;41(12):559-62. Ann Acad Med Singap. 2012. PMID: 23303112 Free article. Clinical Trial.

10

Amprenavir and lopinavir pharmacokinetics following coadministration of amprenavir or fosamprenavir with lopinavir/ritonavir, with or without efavirenz.

Pham PA, Hendrix CW, Barditch-Crovo P, Parsons T, Khan W, Parish M, Radebaugh C, Carson KA, Pakes GE, Qaqish R, Flexner C. Pham PA, et al. Antivir Ther. 2007;12(6):963-9. Antivir Ther. 2007. PMID: 17926651 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

871 results

Search Page

Filters